Lead Product(s) : Sodium Lactate
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase IV
Sponsor : Instituto de Salud Carlos III | Universidad Miguel Hernandez de Elche | Hospital del Mar | Hospital Clinico Universitario de Santiago | Hospital Clínico Universitario de Valencia | Hospital Costa del Sol | Corporacion Parc Tauli | Hospital Clínico Univers
Deal Size : Inapplicable
Deal Type : Inapplicable
Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 23, 2023
Lead Product(s) : Sodium Lactate
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase IV
Sponsor : Instituto de Salud Carlos III | Universidad Miguel Hernandez de Elche | Hospital del Mar | Hospital Clinico Universitario de Santiago | Hospital Clínico Universitario de Valencia | Hospital Costa del Sol | Corporacion Parc Tauli | Hospital Clínico Univers
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Lactate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 05, 2019
Lead Product(s) : Sodium Lactate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Lactate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase III
Sponsor : Boston Children's Hospital | Children's Healthcare of Atlanta | Children's Hospital Colorado | Children's Hospital Los Angeles | The University of Pittsburgh School of Medicine | Morgan Stanley Children’s Hospital | Children's Hospital and Health System F
Deal Size : Inapplicable
Deal Type : Inapplicable
Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 25, 2019
Lead Product(s) : Sodium Lactate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase III
Sponsor : Boston Children's Hospital | Children's Healthcare of Atlanta | Children's Hospital Colorado | Children's Hospital Los Angeles | The University of Pittsburgh School of Medicine | Morgan Stanley Children’s Hospital | Children's Hospital and Health System F
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Lactate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Pneumonia
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 31, 2019
Lead Product(s) : Sodium Lactate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Lactate
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Peritonitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 11, 2018
Lead Product(s) : Sodium Lactate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Lactate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Sepsis.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 04, 2018
Lead Product(s) : Sodium Lactate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Lactate
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Innogene Kalbiotech
Deal Size : Inapplicable
Deal Type : Inapplicable
0.5M Na Lactate Solution in Acute Heart Failure (AHF)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 11, 2013
Lead Product(s) : Sodium Lactate
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Innogene Kalbiotech
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
